Read all issues of IJTLD OPEN for FREE.
Click the title to access the open access PDF.
Volume 1, Number 8 - August 2024
EDITORIAL
Rethinking latent TB? Think again
R.E. Chaisson, P.C. Hopewell
ORIGINAL ARTICLES
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19
M. Bastard, et al.
Yield of TB screening in prisons in Tajikistan
S. Moe, et al.
TB prevention activities in the WHO European Region
A. Matteelli, et al.
Microbiota alterations in patients treated for susceptible or drug-resistant TB
M. Hauptmann, et al.
Antibacterial action of penicillin against Mycobacterium avium complex
D. Deshpande, et al.
LETTERS
TB-related catastrophic costs and associated factors for patients in Ethiopia
Z.G. Dememew, et al.
The TB burden in East Java, Indonesia, post-COVID-19
S. Palupi, et al.
Volume 1, Number 7 - July 2024
EDITORIAL
Update on IJTLD OPEN: the future is open
H.D. Blackbourn, G.B. Migliori
ORIGINAL ARTICLES
A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
M.L. Rekart, et al.
Severe outcomes among adults with TB during COVID-19
T. Jacobs, et al.
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
S. Sweeney, et al.
Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB
E.T. Abbew, et al.
Savings from the introduction of BPaL and BPaLM regimens at the country level
C. Auer, et al.
LETTERS
The implementation of whole-genome sequencing for Mycobacterium tuberculosis in Vietnam
D.T. Huong, et al.
Healthcare-seeking behavior among people with HIV undergoing TB screening during the COVID-19 pandemic
I. Aggarwal, et al.
Screening rates for HIV and diabetes in patients with active TB: results of a nationwide survey in Japan
Y. Kimura, et al.
A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
A. Vasquez, et al.
Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease
J. De Man, et al.
Volume 1, Number 6 - June 2024
EDITORIAL
Embracing novel thinking to safeguard against airborne pathogens in indoor spaces
H. van der Westhuizen, et al.
ORIGINAL ARTICLES
Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines
D. Evans, et al.
Leveraging Global Fund’s investments to expand innovative public-private provider engagement in TB
M.A. Yassin, et al.
The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020
A.N. Shapiro, et al.
Determinant of catastrophic costs associated with treatment for rifampicin-resistant TB in households in the Republic of Moldova
A. Ciobanu, et al.
Real-life use of delamanid: results from the European post-authorisation safety study
N. Schönfeld, et al.
LETTERS
Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease
A. Lemson, et al.
Volume 1, Number 5 - May 2024
EDITORIAL
Comprehensive care for people affected by TB: addressing TB-associated disabilities
M. Calvi, et al.
ORIGINAL ARTICLES
Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
S.A. Adakun, et al.
Prevalence, incidence and determinants of QuantiFERONTM positivity in South African schoolchildren
J. Stewart, et al.
Xpert MTB/XDR implementation in South Africa: cost outcomes of centralised vs. decentralised approaches
N. Cassim, et al.
Mapping TB incidence across districts in Uganda to inform health program activities
N.J. Henry, et al.
TB drug susceptibility testing in high fluoroquinolone resistance settings
F. Saluzzo, et al.
LETTERS
HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
J.S. Zifodya, et al.
Volume 1, Number 4 - April 2024
EDITORIAL
A publicly accessible global data repository – the WHO TB-IPD platform
R. L. Goodall, et al.
ORIGINAL ARTICLES
A pilot cross-sectional study of non-communicable diseases in TB household contacts
Y. Hamada, et al.
Characteristics of and treatment outcomes in rifampicin-intolerant patients
R. Mangat, et al.
TB among refugees from Ukraine in European countries
G. de Vries, et al.
Non-communicable airway disease and air pollution in three African Countries: Benin, Cameroon and The Gambia
B. Awokola, et al.
TB and poverty: the effect of rifampicin-resistant TB on household income
A. Ciobanu, et al.
LETTERS
TB preventive therapy: uptake and time to initiation during implementation of ‘7-1-7’
A. D. Harries, et al.
Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings
M. Mbenga, et al.
Volume 1, Number 3 - March 2024
EDITORIAL
Guidelines for the diagnosis and management of post-TB lung disease: a call to action
D.R. Silva, S. Inwentarz
VIEWPOINT
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
G.B. Migliori, et al.
STATE OF THE ART
Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes
B.W. Allwood, et al.
ORIGINAL ARTICLES
Health system costs of providing outpatient care for diabetes in people with TB in the Philippines
T. Yamanaka, et al.
Chronic obstructive pulmonary disease related to wood smoke and impact of the combined exposure to tobacco
C. A. Torres-Duque, et al. .
2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment
M. van den Boom, et al.
LETTER
Impact of the private sector on spatial accessibility to chest radiography services in Lima, Peru
Y. Xiong, et al.
Psychosocial needs of adolescents living with TB in Peru and South Africa
C. Cintron, et al.
Volume 1, Number 2 - February 2024
EDITORIAL
Applying ‘timeliness’ to the screening and prevention of TB in household contacts of pulmonary TB patients
A. D. Harries, et al.
ORIGINAL ARTICLES
A social enterprise model for TB detection and treatment through the private sector in Pakistan
S. M. A. Zaidi, et al.
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
D. T. Wademan, et al. .
Evaluation of a short training course of chest X-ray interpretation for the diagnosis of paediatric TB
B. F. Melingui, et al.
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
A. Musinguzi, et al.
Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB
P. S. Rao, et al.
LETTER
A call to invest in post-TB lung disease to halt TB transmission in communities
P. M. Mbelele, et al.
CORRESPONDENCE
Assessing for comorbidities, determinants and disability during TB treatment
K. Viney, et al.
Volume 1, Number 1 - January 2024
EDITORIALS
Launch of IJTLD OPEN: a new home for open access papers on respiratory disease
H. D. Blackbourn & G. B. Migliori
Global reporting on TB in children and adolescents: how far have we come and what remains to be done?
S. Verkuijl, et al.
More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
G. B. Migliori, et al.
ORIGINAL ARTICLES
Characteristics of TPT initiation and completion among people living with HIV
L. Gunde, et al.
Screening of household contacts for TB infection in Cote d'Ivoire
R. K. N’Guessan, et al.
Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa
C. Bekker, et al.
Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
E. Commiesie, et al
Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in Kenya
D. Nair, et al.
Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
M. van den Boom, et al.
LETTER
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis
P. Confalonieri, et al.